Professors Yeonhee Park, Heekyung Ahn, and Jiyeon Kim from Samsung Medical Center;s Hematology and Oncology Department, along with Professor Seokah Lim from Seoul National University Hospital;s Hematology and Oncology Department, and the Korean Ca...
On March 4, Seungwoo Park, President of Samsung Medical Center, delivered a keynote address at ;HIMSS 2025,; the world;s largest medical IT conference, held in Las Vegas, USA. This marks the first time in HIMSS (Healthcare Information and Manageme...
A research team, led by Professor Park, Jun Hee from the Health Promotion Center at Samsung Medical Center and Professor Won, Jang Won from the Department of Family Medicine at Kyung Hee University Hospital (including Dr. Shin, Hyung Eun and Profe...
We were delighted to meet with H.E. Sukhee SUKHBOLD, the Ambassador of Mongolia to Korea, at SMC.During the visit, we had meaningful disscusstion on strengthening cooperation in various healthcare fields.;We look forward to continued collaboration.;
;On February 13, the Siloam Hospital;visited SMC to discuss mutual cooperation and exchange valuable insights.;We look forward to continued collaboration!
Research indicates that the extent of muscle loss following chemotherapy plays a critical role in determining local treatment options, including surgery, and that greater muscle loss negatively impacts treatment outcomes in pancreatic cancer patie...
;On February 11, the NUHS visited SMC to discuss mutual cooperation and exchange valuable insights.;We look forward to continued collaboration!
Samsung Medical Center is the first in Korea to establish a CAR T-cell Therapy Center and is operating a multidisciplinary-based treatment system. The professors from the Department of Hematology-Oncology and the Department of Pediatrics, along wi...
;On January 8, 2025, we were delighted to host students from Tung Wah College, Hong Kong, for a successful Study Visit at SMC!During the workshop, the students engaged in dynamic discussions on SMC Smart Hospital and the essence of Life at SMC, fo...
The Pulmonary Hypertension Center at the Heart Vascular Stroke Institute of Samsung Medical Center has successfully performed 500 pulmonary vascular interventions, a first in Korea. It has been 10 years since the Pulmonary Hypertension Center perf...
;For the first time in Korea, Samsung Medical Center has surpassed 200 Left Ventricular Assist Device (LVAD) surgeries. Since October 2018, LVADs, commonly known as artificial hearts, have been covered by health insurance, resulting in an increase...
Professor Young-Keun On from the Department of Cardiology at SMC has successfully performed a cutting-edge treatment for atrial fibrillation known as Pulsed Field Ablation (PFA). PFA is a procedure that uses high-energy electrical pulses to select...
